AI CAPITAL INTELLIGENCE
WhiteLab Genomics funding history
1 recorded financing disclosures for WhiteLab Genomics. Dates, rounds, currencies and original sources follow the individual records. This is not a complete company funding history.
Latest recorded funding, at a glance
The latest disclosure recorded for WhiteLab Genomics is dated 2026-10-06: Series B, EUR 23,200,000. Named investors: AVP, Yaday Health, Blast Club, Omnes Capital, Debiopharm Innovation Fund. This is the latest record in our coverage, not a claim about all company financing.
Verify this disclosure · Original source 1 · Original source 2
Disclosures and evidence
| Disclosure date | Round | Disclosed amount | Named investors | Evidence |
|---|---|---|---|---|
| Series B | EUR 23,200,000 | AVP, Yaday Health, Blast Club, Omnes Capital, Debiopharm Innovation Fund | Record · Source 1 · Source 2 |
Recorded financing disclosures
- WhiteLab Genomics2026-10-06 · Series B · EUR 23,200,000
Disclosed investors across recorded rounds
Publicly disclosed founding team
- David Del Bourgo · 联合创始人兼CEO
- Lucia Cinque · 联合创始人
- Julien Cottineau · 联合创始人